1-20 of 32
Elisa Sala
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Resolve AML 001: An Adaptive Open-Label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of Cctx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients with r/r AML

Marion Subklewe, Nicolas Boissel, Stephan Mielke, Pere Barba, Elisa Sala, Eric Deconinck, Olivia Fiere, Jonathan Jaeger, Chloe Vasseghi, Marina Deschamps, Christophe Ferrand, Edouard De Dreuzy, Richard Sainson, Jens Hasskarl
Journal: Blood
Blood (2024) 144 (Supplement 1): 2883.2.
https://doi.org/10.1182/blood-2024-203204
Published: 2024
Journal Articles

Impact of FLT3 Inhibitor Maintenance Therapy on Post-Transplant Outcomes in FLT3-Mutated AML Patients: A Real World Analysis from the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST)

Radwan Massoud, Sarah Flossdorf, Franziska Hanke, Thomas Schroeder, Wolfgang Andreas Bethge, Robert Zeiser, Caroline Pabst, Gerald Wulf, Elisa Sala, Inken Hilgendorf, Christof Scheid, Matthias Edinger, Friedrich Stölzel, Igor Wolfgang Blau, Matthias Stelljes, Guido Kobbe, Uwe Platzbecker, Jörg Bittenbring, Matthias Eder, Katharina Fleischhauer, Andreas Burchert, Christoph Schmid, Nicolaus Kroeger
Journal: Blood
Blood (2024) 144 (Supplement 1): 3560.
https://doi.org/10.1182/blood-2024-210920
Published: 2024
Journal Articles

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation for T-Cell Prolymphocytic Leukemia - a Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Joanna Drozd-Sokolowska, Luuk Gras, Laurien Baaij, Linda Koster, Emma Nicholson, Peter Dreger, Tobias Gedde-Dahl, Stephan Mielke, Urpu Salmenniemi, Grzegorz Basak, Patrice Chevallier, Gerald Wulf, Johannes Schetelig, Jan-Erik Johansson, Arnon Nagler, Stéphanie Nguyen Quoc, Victoria Potter, Elisa Sala, Anna Bergendahl Sandstedt, Yener Koc, Robert Zeiser, Michel van Gelder, Wieslaw Wiktor Jedrzejczak, Kavita K Raj, Olivier Tournilhac, Donal P McLornan
Journal: Blood
Blood (2024) 144 (Supplement 1): 600.
https://doi.org/10.1182/blood-2024-198075
Published: 2024
Journal Articles

The Impact of CMV-Prophylaxis with Letermovir on Immune Reconstitution after Allogeneic Stem Cell Transplantation: Single-Center Analysis of 363 Transplanted Patients

Adela Maria Neagoie, Conrad Weidt, Daniel Fürst, Verena Wais, Christian Sinzger, Katrin Strauss, Katharina Göhring, Jacqueline Schnell, Michaela Feuring, Thomas Stamminger, Hartmut Döhner, Donald Werner Bunjes, Elisa Sala
Journal: Blood
Blood (2024) 144 (Supplement 1): 2153.
https://doi.org/10.1182/blood-2024-207092
Published: 2024
Journal Articles

Updated Results from a Phase I Dose Escalation Study of the Rapidly-Switchable Universal CAR-T Therapy UniCAR-T-CD123 in Relapsed/Refractory AML

Martin Wermke, Stephan Metzelder, Sabrina Kraus, Elisa Sala, Vladan Vucinic, Walter Fiedler, Katrin Wetzko, Jonas Schäfer, Maria-Elisabeth Goebeler, Jan Koedam, Kristin Franke, Matti Vänskä, Armin Ehninger, Marc Cartellieri, Gerhard Ehninger, Tapan Maniar
Journal: Blood
Blood (2023) 142 (Supplement 1): 3465.
https://doi.org/10.1182/blood-2023-177867
Published: 2023
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Advanced Systemic Mastocytosis

Deborah Christen, Johannes Lübke, Anne Kaiser, Juliana Schwaab, Khalid Shoumariyeh, Madlen Jentzsch, Katja Sockel, Judith Schaffrath, Francis A. Ayuk, Matthias Stelljes, Inken Hilgendorf, Elisa Sala, Jennifer Kaivers, Stefan Schönland, Christoph Wittke, Bernd Hertenstein, Markus P. Radsak, Ulrich Kaiser, Valeska Brückl, Nicolaus Kröger, Stefan Klein, Wolf-Karsten Hofmann, Tim H. Brümmendorf, Edgar Jost, Jens Panse, Andreas Reiter
Journal: Blood
Blood (2023) 142 (Supplement 1): 3605.
https://doi.org/10.1182/blood-2023-178304
Published: 2023
Journal Articles

Treosulfan-Based Reduced-Toxicity Conditioning for Elderly Patients with High-Risk Myelodysplastic and Myeloproliferative Disease for Allogeneic Hematopoietic Stem Cell Transplantation

Adela Maria Neagoie, Verena Wais, Andrea Gantner, Jacqueline Schnell, Katrin Strauss, Conrad Weidt, Hartmut Dohner, Donald Werner Bunjes, Elisa Sala
Journal: Blood
Blood (2023) 142 (Supplement 1): 6956.
https://doi.org/10.1182/blood-2023-188767
Published: 2023
Journal Articles

Phase 1 Dose Escalation Study of the Rapidly Switchable Universal CAR-T Therapy Unicar-T-CD123 in Relapsed/Refractory AML

Gerhard Ehninger, Sabrina Kraus, Elisa Sala, Stephan K Metzelder, Vladan Vucinic, Walter Fiedler, Maria-Elisabeth Goebeler, Jan Moritz Middeke, Malte von Bonin, Carla Kreissig, Jan Koedam, Marc Cartellieri, Armin Ehninger, Martin Wermke, Jonas A. Schäfer
Journal: Blood
Blood (2022) 140 (Supplement 1): 2367–2368.
https://doi.org/10.1182/blood-2022-168877
Published: 2022
Journal Articles

Feasibility and Efficacy of Romiplostim for the Treatment of Persistent Thrombocytopenia after Allogeneic Stem Cell Transplantation. a Single Centre Experience

Charlotte Sommer, Andrea Gantner, Verena Wais, Adela Neagoie, Jacqueline Schnell, Hartmut Döhner, Donald Bunjes, Elisa Sala
Journal: Blood
Blood (2022) 140 (Supplement 1): 7603–7604.
https://doi.org/10.1182/blood-2022-168543
Published: 2022
Journal Articles

Monitoring the in-Vivo Expansion and Persistence of CAR-T Cells As a Tool to Help Decision Making in Patients with Aggressive B-Cell Lymphoma

Daniel Fürst, Christine Neuchel, Adela Neagoie, Elisa Amann, Immanuel Rode, Angela Krauss, Hubert Schrezenmeier, Verena Wais, Hartmut Döhner, Andreas Viardot, Elisa Sala
Journal: Blood
Blood (2022) 140 (Supplement 1): 7527–7528.
https://doi.org/10.1182/blood-2022-169212
Published: 2022
Journal Articles

Risk Factors Influencing Humoral Response to COVID 19 Vaccination after Allogeneic Stem Cell Transplantation

Marie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, Lam Giang Vuong, Maral Saadati, Axel Benner, Lars Bullinger, Hartmut Döhner, Donald Bunjes, Elisa Sala
Journal: Blood
Blood (2022) 140 (Supplement 1): 4755–4756.
https://doi.org/10.1182/blood-2022-170006
Published: 2022
Journal Articles

Donor Genetic Determinant of Thymopoiesis rs2204985 Impacts Clinical Outcome after Single HLA Mismatched HSCT

Chrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, Elisa Sala, Thomas Valerius, Gerald Wulf, Eva Maria Wagner, Nicolaus Kroeger, Niels Murawski, Hermann Einsele, Kerstin Schaefer-Eckart, Sebastian Freitag, Jochen Casper, Martin Kaufmann, Mareike Dürholt, Bernd Hertenstein, Stefan Klein, Mark Ringhoffer, Christine Neuchel, Immanuel Rode, Joannis Mytilineos, Hubert Schrezenmeier, Daniel Fürst
Journal: Blood
Blood (2021) 138 (Supplement 1): 3903.
https://doi.org/10.1182/blood-2021-144748
Published: 2021
Journal Articles

COVID-19 Vaccination after Allogeneic Stem Cell Transplantation: Real Word Data on Safety and Efficacy. a Single Center Experience.

Adela Neagoie, Charlotte Sommer, Andrea Gantner, Verena Wais, Jacqueline Schnell, Hannah Simon, Andreas Viardot, Hartmut Döhner, Donald Bunjes, Elisa Sala
Journal: Blood
Blood (2021) 138 (Supplement 1): 4868.
https://doi.org/10.1182/blood-2021-151061
Published: 2021
Journal Articles

Mapping the Evolution of the Mutational Landscape of Acute Myeloid Leukemia from Diagnosis to Post-Transplantation Relapse and Its Interplay with Immune Evasion Mechanisms

Elisa Sala, MD, Francesca Biavasco, MD, Gabriele Bucci, PhD, Cristina Toffalori, PhD, Donatella Biancolini, PhD, Elena Antonini, MSc, Matteo Giovanni Carrabba, MD, Bernhard Gentner, MD, Cristina Tresoldi, MSc, Massimo Bernardi, MD, Dejan Lazarevic, MD, Giovanni Tonon, MD, Fabio Ciceri, MD, Luca Vago, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 511.
https://doi.org/10.1182/blood-2019-124725
Published: 2019
Journal Articles

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Elisa Sala, MD, Stephanie von Harsdorf, MD, Verena Wais, MD, Thanh Mai Anne Nguyen, MD, Raphael Beck, MD, Hartmut Döhner, MD, Donald Bunjes, MD, Florian Kuchenbauer, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4601.
https://doi.org/10.1182/blood-2018-99-114977
Published: 2018
Journal Articles

Risk Factors Determining the Outcome of Critically Ill Allogeneic Hematopoietic Stem Cell Transplantation Patients: Time to Step Down?

Verena Wais, MD, Carmen Huwe, Armin Imhof, Hendrik Bracht, Thanh Mai Anne Nguyen, MD, Elisa Sala, MD, Hartmut Döhner, MD, Stephanie von Harsdorf, MD, Donald Bunjes, MD, Florian Kuchenbauer, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2135.
https://doi.org/10.1182/blood-2018-99-115280
Published: 2018
Journal Articles

cGvHD — CIBMTR Risk Score Stratification in 207 Consecutive Adults after Unmanipulated PBSC Haploidentical Stem Cell Transplantation

Maria Teresa Lupo Stanghellini, MD, Francesca Lorentino, MD, Gabriele Antonarelli, Elisa Sala, MD, Raffaella Greco, MD, Mara Morelli, MD, Magda Marcatti, MD, Simona Piemontese, MD, Andrea Assanelli, MD, Matteo Giovanni Carrabba, MD, Fabio Serpenti, Fabio Giglio, MD, Sara Mastaglio, MD, Sarah Marktel, MD, Francesca Lunghi, MD, Elena Guggiari, MD, Francesca Pavesi, MD, Luca Vago, MD PhD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Fabio Ciceri, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4499.
https://doi.org/10.1182/blood.V130.Suppl_1.4499.4499
Published: 2017
Journal Articles

Voriconazole and Non-Melanoma Skin Cancer after Allogeneic HSCT: Results of a Prospective Dedicated Follow-up Program in 302 Patients

Maria Teresa Lupo-Stanghellini, MD, Raffaella Greco, MD, Andrea Angelo Assanelli, MD, Tommaso Perini, MD, Elena Guggiari, MD, Francesca Lorentino, MD, Simona Piemontese, MD, Mara Morelli, MD, Gabriele Antonarelli, Fabio Giglio, MD, Serena Camilla Dalto, MD, Sara Mastaglio, MD, Elisa Sala, MD, Francesca Pavesi, MD, Matteo Giovanni Carrabba, MD, Magda Marcatti, MD, Sarah Marktel, MD, Stefania Girlanda, MD, Carlo Messina, MD, Luca Vago, MD PhD, Francesca Lunghi, MD, Massimo Bernardi, MD, Consuelo Corti, MD, Chiara Bonini, MD, Jacopo Peccatori, MD, Fabio Ciceri, MD
Journal: Blood
Blood (2016) 128 (22): 3442.
https://doi.org/10.1182/blood.V128.22.3442.3442
Published: 2016
Journal Articles

Disease Risk Index (DRI) Score Stratification and Composite End-Point GvHD-Free Relapse-Free Survival (GRFS) May Optimize Transplant Decision-Making Process in Haploidentical Stem Cell Transplantation

Maria Teresa Lupo-Stanghellini, MD, Gabriele Antonarelli, Francesca Lorentino, MD, Elisa Sala, MD, Mara Morelli, MD, Raffaella Greco, MD, Magda Marcatti, MD, Simona Piemontese, MD, Tommaso Perini, MD, Andrea Angelo Assanelli, MD, Matteo Giovanni Carrabba, MD, Alessandra Forcina, MD, Serena Camilla Dalto, MD, Sara Mastaglio, MD, Sarah Marktel, MD, Francesca Lunghi, MD, Elena Guggiari, MD, Fabio Giglio, MD, Francesca Pavesi, MD, Luca Vago, MD PhD, Massimo Bernardi, MD, Consuelo Corti, MD, Jacopo Peccatori, MD, Fabio Ciceri, MD
Journal: Blood
Blood (2016) 128 (22): 3492.
https://doi.org/10.1182/blood.V128.22.3492.3492
Published: 2016
Journal Articles

Post-Transplant Treatment with Ponatinib for Patients with High-Risk Philadelphia Chromosome Positive Leukemia

Maria Teresa Lupo-Stanghellini, MD, Francesca Lunghi, MD, Andrea Angelo Assanelli, MD, Elena Guggiari, MD, Raffaella Greco, MD, Mara Morelli, MD, Tommaso Perini, MD, Serena Camilla Dalto, MD, Elisa Sala, MD, Francesca Lorentino, MD, Simona Piemontese, MD, Francesca Pavesi, MD, Sara Mastaglio, MD, Daniele Mannina, MD, Carlo Messina, MD, Luca Vago, MD PhD, Sarah Marktel, MD, Matteo Giovanni Carrabba, MD, Magda Marcatti, MD, Massimo Bernardi, MD, Consuelo Corti, MD, Chiara Bonini, MD, Jacopo Peccatori, MD, Fabio Ciceri, MD, Fabio Giglio, MD
Journal: Blood
Blood (2016) 128 (22): 5810.
https://doi.org/10.1182/blood.V128.22.5810.5810
Published: 2016